Newsroom

Court Affirms Potential $450 Million Settlement with Apple in E-books Price-Fixing Class Action

June 30, 2015

Hagens Berman attorneys representing a class of e-book purchasers announced today that the Second Circuit has affirmed a District Court ruling, bringing consumers one step closer to a proposed $450 million settlement with Apple (NASDAQ: AAPL) for its role in an alleged e-book price-fixing scheme with five of the nation’s largest publishing companies. More »

Class Action Alleges Novartis Gleevec Patent Infringement Suit a Sham

June 24, 2015

A class-action lawsuit filed against Novartis alleges that the pharma company’s patent infringement suit against generic company Sun Pharma was a sham, and seeks a permanent injunction to prevent Novartis or Sun from enforcing the terms of a settlement agreement that, barring relief, will delay the launch of generic Gleevec for months. More »

Hagens Berman Advises Investors in Toshiba Corporation (OTC: TOSYY, TOSBF) of August 3, 2015 Lead Plaintiff Deadline in Restatement Class Action

June 23, 2015

Hagens Berman advises investors of the August 3, 2015 lead plaintiff deadline in the securities fraud class action lawsuit filed against Toshiba Corporation as a result of admitted accounting irregularities. More »

Hagens Berman Reminds Investors They Have Less Than Two Weeks to Move before June 29th Lead Plaintiff Deadline in Case Against Trinity Industries, Inc. (NYSE: TRN)

June 17, 2015

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors with losses over $50,000 of the June 29, 2015 lead plaintiff deadline in a class action lawsuit filed against Trinity Industries, Inc. More »

Hagens Berman Reminds Investors With Losses Greater than $100,000 in CHC Group Ltd. (NYSE: HELI) of the July 17th Lead Plaintiff Deadline in IPO-Related Lawsuit

June 16, 2015

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors with losses over $100,000 of the July 17, 2015 lead plaintiff deadline in the securities fraud class action lawsuit filed against CHC Group Ltd. More »

General Motors Consumer Lawsuit Alleges Mail and Wire Fraud in GM’s Concealment of Ignition Switch Defect

June 12, 2015

Consumers represented by co-lead counsel Hagens Berman and Lieff Cabraser today filed an expanded class-action complaint against General Motors, bringing RICO claims against New GM based on new information from the lawsuit’s discovery phase that indicates New GM committed mail and wire fraud in connection with the ignition switch defect that causes cars to stall unexpectedly and disables the cars’ airbags. More »

Hagens Berman Files Class-Action Suit Against IsoRay, Inc. Alleging Securities Fraud

June 11, 2015

Hagens Berman today announced that a class action has been commenced in the United States District Court for the Eastern District of Washington on behalf of purchasers of IsoRay, Inc. (NYSE: ISR) publicly traded securities during the period between May 20, 2015 and May 21, 2015 (the "Class Period"). More »

Hagens Berman Reminds Investors They Have Two Weeks to Move before the June 22nd Lead Plaintiff Deadline in Case against Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)

June 9, 2015

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors they have two weeks before the June 22, 2015 lead plaintiff deadline in a class action lawsuit filed against Cellular Biomedicine Group, Inc. More »

Hagens Berman Alerts Toshiba Corporation (OTC: TOSYY, TOSBF) Investors with losses over $100,000 of the August 3, 2015 Lead Plaintiff Deadline

June 9, 2015

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, advises investors of the August 3, 2015 lead plaintiff deadline in the securities fraud class action lawsuit filed against Toshiba Corporation. More »

Hagens Berman Reminds Investors with losses over $100,000 in Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) of the June 29th Lead Plaintiff Deadline

June 9, 2015

Hagens Berman Reminds Investors with losses over $100,000 in Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) of the June 29th Lead Plaintiff Deadline More »